Bavarian Nordic Washington, DC, INC.

Pharmaceutical company

Based in DC

🤖

AI Overview

With $570K in lobbying spend across 26 quarterly filings, Bavarian Nordic Washington, DC, INC is an active lobbying client. Their lobbying covers 1 issue area. Active from 2018 to 2024.

$570K

Total Spend

Years Active

Firms Hired

Lobbyists Deployed

Issues Lobbied

Spending Trend

View as table

Year	Lobbying Spend
2018	$70K
2019	$60K
2020	$60K
2021	$100K
2022	$120K
2023	$120K
2024	$40K

Issues Lobbied

Health Issues

Lobbying Firms

Baker Donelson Bearman Caldwell & Berkowitz

Lobbyists

Nicole Carelli Thomas Daschle

Government Agencies Targeted

These are the government entities that Bavarian Nordic Washington, DC, INC. disclosed contacting in their lobbying filings.

SENATEWhite House OfficeOffice of Management & Budget (OMB)HOUSE OF REPRESENTATIVESExecutive Office of the President (EOP)

View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues

Authorization and appropriations for medical countermeasures development and procurement.

H.R. 6378/S. 2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act.

H.R. 269, The Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, provisions related to authorization for medical countermeasures development and procurement; medical counterme

H.R. 269, The Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 and S. 1379, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, provisions related to